Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial
Titel:
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial
Auteur:
Schweighardt, Becky Tompkins, Troy Lau, Kelly Jesaitis, Lynne Qi, Yulan Musson, Donald G. Farmer, Pamela Haller, Christine Shaywitz, Adam J. Yang, Ke O’Neill, Charles A.
Verschenen in:
Clinical therapeutics
Paginering:
Jaargang 37 (2015) nr. 5 pagina's 1.020998989E9 p.